NASDAQ:SWKHL • US78501P3029
The current stock price of SWKHL is 25.7 USD. In the past month the price increased by 0.78%. In the past year, price increased by 2.39%.
ChartMill assigns a technical rating of 7 / 10 to SWKHL. When comparing the yearly performance of all stocks, SWKHL turns out to be only a medium performer in the overall market: it outperformed 40.22% of all stocks.
ChartMill assigns a fundamental rating of 6 / 10 to SWKHL. SWKHL is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average.
Over the last trailing twelve months SWKHL reported a non-GAAP Earnings per Share(EPS) of 2.17. The EPS increased by 121.43% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 50.36% | ||
| ROA | 7.85% | ||
| ROE | 8.94% | ||
| Debt/Equity | 0.13 |
6 analysts have analysed SWKHL and the average price target is 32.44 USD. This implies a price increase of 26.23% is expected in the next year compared to the current price of 25.7.
For the next year, analysts expect an EPS growth of 70.79% and a revenue growth 6.17% for SWKHL
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| HASI | HA SUSTAINABLE INFRASTRUCTUR | 12.94 | 4.7B | ||
| BUR | BURFORD CAPITAL LTD | 7.09 | 2.112B | ||
| ACTG | ACACIA RESEARCH CORP | N/A | 415.527M | ||
| SWKH | SWK HOLDINGS CORP | 7.8 | 202.07M | ||
| SUIG | SUI GROUP HOLDINGS LTD | N/A | 100.515M | ||
| MLCI | MOUNT LOGAN CAPITAL INC | N/A | 66.124M | ||
| FTFT | FUTURE FINTECH GROUP INC | N/A | 8.232M | ||
| SHFS | SHF HOLDINGS INC | N/A | 2.895M |
View all stocks in the Specialized Finance Industry | View all stocks in the Financials Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
SWK Holdings Corp. engages in financial and asset management in the field of pharmaceuticals. The company is headquartered in Dallas, Texas and currently employs 9 full-time employees. The firm provides non-dilutive financing to fuel the development and commercialization of lifesaving and life-enhancing medical technologies and products. The firm's solutions include structured debt, traditional royalty monetization, synthetic royalty transactions, and asset purchases typically ranging in size from $5.0 million to $25.0 million.
SWK HOLDINGS CORP - SWKH 9 01/31/27
5956 Sherry Lane, Suite 650
Dallas TEXAS US
Employees: 24
Phone: 12142177253
SWK Holdings Corp. engages in financial and asset management in the field of pharmaceuticals. The company is headquartered in Dallas, Texas and currently employs 9 full-time employees. The firm provides non-dilutive financing to fuel the development and commercialization of lifesaving and life-enhancing medical technologies and products. The firm's solutions include structured debt, traditional royalty monetization, synthetic royalty transactions, and asset purchases typically ranging in size from $5.0 million to $25.0 million.
The current stock price of SWKHL is 25.7 USD. The price increased by 0.2% in the last trading session.
SWK HOLDINGS CORP - SWKH 9 01/31/27 (SWKHL) has a dividend yield of 8.75%. The yearly dividend amount is currently 0.
SWKHL has a ChartMill Technical rating of 7 out of 10 and a ChartMill Fundamental rating of 6 out of 10.
SWKHL stock is listed on the Nasdaq exchange.
The next ex-dividend date for SWK HOLDINGS CORP - SWKH 9 01/31/27 (SWKHL) is December 15, 2025.
The Revenue of SWK HOLDINGS CORP - SWKH 9 01/31/27 (SWKHL) is expected to grow by 6.17% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.